Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity
Related Experiment Video
Updated: Feb 24, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Jayashree Thatte1, Lawrence Banks2
1International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Abstract:
The human papillomavirus (HPV) E6 oncoproteins recruit the cellular ubiquitin ligase E6AP/UBE3A to target cellular substrates for proteasome-mediated degradation, and one consequence of this activity is the E6 stimulation of E6AP autoubiquitination and degradation. Recent studies identified an autism-linked mutation within E6AP at T485, which was identified as a protein kinase A phosphoacceptor site and which could directly regulate E6AP ubiquitin ligase activity. In this study, we have analyzed how T485-mediated regulation of E6AP might affect E6 targeting of some of its known substrates. We show that modulation of T485 has no effect on the ability of E6 to direct either p53 or Dlg for degradation. Furthermore, T485 regulation has no effect on HPV-16 or HPV-31 E6-induced autodegradation of E6AP but does affect HPV-18 E6-induced autodegradation of E6AP. In cells derived from cervical cancers, we find low levels of both phosphorylated and nonphosphorylated E6AP in the nucleus. However, ablation of E6 results in a dramatic accumulation of phospho-E6AP in the cytoplasm, whereas nonphosphorylated E6AP accumulates primarily in the nucleus. Interestingly, E6AP phosphorylation at T485 confers association with 14-3-3 proteins, and this interaction seems to be important, in part, for the ability of E6 to recruit phospho-E6AP into the nucleus. These results demonstrate that HPV E6 overrides the normal phosphoregulation of E6AP, both in terms of its enzymatic activity and its subcellular distribution.IMPORTANCE Recent reports demonstrate the importance of phosphoregulation of E6AP for its normal enzymatic activity. Here, we show that HPV E6 is capable of overriding this regulation and can promote degradation of p53 and Dlg regardless of the phosphorylation status of E6AP. Furthermore, E6 interaction with E6AP also significantly alters how E6AP is subject to autodegradation and suggests that this is not a simple stimulation of an already-existing activity but rather a redirection of E6AP activity toward itself. Furthermore, E6-mediated regulation of the subcellular distribution of phospho-E6AP appears to be dependent, in part, upon the 14-3-3 family of proteins.
Insights
Human papillomavirus (HPV) E6 oncoproteins disrupt E6AP/UBE3A phosphoregulation, affecting its activity and cellular location. HPV E6 overrides normal E6AP control, promoting substrate degradation and altering E6AP
Area of Science:
- Virology and Molecular Biology
- Cellular Ubiquitination and Protein Degradation
Background:
- Human papillomavirus (HPV) E6 oncoproteins utilize cellular E6AP/UBE3A ligase for substrate degradation.
- E6AP phosphorylation at T485 regulates its ligase activity, with mutations linked to autism.
- HPV E6's interaction with E6AP influences E6AP's autoubiquitination and degradation.
Purpose of the Study:
- To investigate how T485-mediated E6AP regulation affects E6 targeting of cellular substrates.
- To determine the impact of E6AP phosphorylation status on E6-induced E6AP autodegradation.
- To elucidate the role of E6AP phosphorylation and 14-3-3 proteins in E6-mediated subcellular localization.
Main Methods:
- Analysis of E6-mediated degradation of p53 and Dlg following modulation of E6AP T485.
- Assessment of HPV-16, HPV-31, and HPV-18 E6-induced E6AP autodegradation.
- Cellular fractionation and Western blot analysis to examine phospho-E6AP and non-phospho-E6AP localization.
- Investigation of E6AP association with 14-3-3 proteins.
Main Results:
- Modulation of E6AP T485 did not affect E6-mediated degradation of p53 or Dlg.
- T485 regulation impacted HPV-18 E6-induced E6AP autodegradation but not HPV-16 or HPV-31.
- HPV E6 ablation led to cytoplasmic accumulation of phospho-E6AP and nuclear accumulation of non-phospho-E6AP.
- E6AP phosphorylation at T485 conferred 14-3-3 protein association, influencing nuclear import of phospho-E6AP.
Conclusions:
- HPV E6 overrides normal E6AP phosphoregulation, affecting both enzymatic activity and subcellular distribution.
- E6-mediated E6AP degradation is not a simple stimulation but a redirection of E6AP activity.
- E6-mediated regulation of phospho-E6AP's subcellular distribution involves 14-3-3 proteins.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Mitogens and the Cell Cycle
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Restarting Stalled Replication Forks
Epigenetic Regulation
X-chromosome...

